Related Experiment Video

Updated: Jun 6, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

[The role of pathology in the predictive oncology of solid tumours]

Pavel Fabian1

  • 1Oddelení onkologické a experimentální patologie. Masarykův onkologický ústav, Brno. fabian@mou.cz

Casopis Lekaru Ceskych
|December 3, 2010
PubMed

Insights

Predictive diagnostics in oncology are crucial for targeted therapy response. Testing tumor tissue for specific molecules, like hormone receptors and HER2, guides personalized cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Pathology

Background:

  • Targeted therapies represent a new generation of cancer treatments.
  • Identifying specific molecular targets in tumors is essential for predicting treatment efficacy.
  • Current diagnostic methods are evolving to support personalized oncology.

Purpose of the Study:

  • To demonstrate the process of predictive diagnostics in oncology.
  • To illustrate the role of molecular testing in guiding targeted therapy.
  • To describe the implementation of predictive oncology in the Czech Republic.

Main Methods:

  • Utilizing steroid hormone receptors and HER2 status testing as a model system.
  • Analyzing tumor tissue for the presence of predictive molecular markers.
  • Describing the operational framework of predictive oncology laboratories.

Main Results:

  • The study demonstrates a model for predictive diagnostics in oncology.
  • Testing for molecular targets like hormone receptors and HER2 predicts therapy response.
  • The establishment of six predictive oncology laboratories in the Czech Republic is detailed.

Conclusions:

  • Predictive diagnostics are integral to modern oncology.
  • Molecular testing of tumor tissue is key to successful targeted therapy.
  • Surgical pathology plays a vital role in the predictive oncology ecosystem.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...